共 19 条
[1]
DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS
[J].
ARTHRITIS AND RHEUMATISM,
1992, 35 (06)
:630-640
[4]
Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma
[J].
NATURE CLINICAL PRACTICE RHEUMATOLOGY,
2007, 3 (12)
:682-683
[5]
Dong GF, 2003, CHINESE MED J-PEKING, V116, P543
[7]
Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus
[J].
NATURE CLINICAL PRACTICE RHEUMATOLOGY,
2008, 4 (07)
:352-353
[9]
Pan HN, 2004, CELL MOL IMMUNOL, V1, P43

